DR. LEE G DANTE, MD
Psychiatric in Merion Station, PA
License number
Pennsylvania MD014206E
Category
Psychiatric
Type
Psychiatry
License number
Pennsylvania D29330
Category
Psychiatric
Type
Psychiatry
Address
Address
321 Berkeley Rd, Merion Station, PA 19066
Phone
(610) 667-5448
(610) 667-8117 (Fax)
(610) 667-8117 (Fax)
Personal information
See more information about LEE G DANTE at radaris.comName
Address
Phone
2801 Island Ave, Philadelphia, PA 19153
321 Berkley Rd, Merion, PA 19066
2801 Island Ave, Philadelphia, PA 19153
Merion Station, PA
6 6678, Merion Station, PA 19066
Professional information
See more information about LEE G DANTE at trustoria.com
Dr. Lee G Dante, Merion Station PA - MD (Doctor of Medicine)
Dr. Lee G Dante, Merion Station PA - MD (Doctor of Medicine)
Specialties:
Psychiatry
Address:
Lee Dante MD
321 Berkley Rd, Merion Station 19066
(610) 667-5448 (Phone)
321 Berkley Rd, Merion Station 19066
(610) 667-5448 (Phone)
Languages:
English
Hospitals:
Lee Dante MD
321 Berkley Rd, Merion Station 19066
Pennsylvania Hospital
800 Spruce St, Philadelphia 19107
321 Berkley Rd, Merion Station 19066
Pennsylvania Hospital
800 Spruce St, Philadelphia 19107
Education:
Medical School
University Of Pennsylvania School Of Medicine
Graduated: 1972
Penn Hospital
Institute Penn Hospital
University Of Pennsylvania School Of Medicine
Graduated: 1972
Penn Hospital
Institute Penn Hospital
Background:
Sanctions: 2 time(s)
Composition And Method Of Treating Depression Using Natoxone Or Naltrexone In Combination With A Serotonin Reuptake Inhibitor
Composition And Method Of Treating Depression Using Natoxone Or Naltrexone In Combination With A Serotonin Reuptake Inhibitor
US Patent:
5512593, Apr 30, 1996
Filed:
Mar 2, 1993
Appl. No.:
8/031096
Inventors:
Lee G. Dante - Merion Station PA
International Classification:
A01N 4338
US Classification:
514410
Abstract:
A new composition and method of treating depression includes administering to a depressed patient a pharmacologically effective dose of naloxone or naltrexone or their pharmacologically effective salts and esters in combination with at least one nontricyclic serotonin reuptake inhibitor antidepressant or their pharmacologically effective salts and esters. The patient may while undergoing antidepressant therapy be undergoing treatment with a benzodiazepine for anxiety.
Method For Treating Emotional Or Mental Illness And Emotional Or Mental Illness Concomitant With Seizures
Method For Treating Emotional Or Mental Illness And Emotional Or Mental Illness Concomitant With Seizures
US Patent:
6034091, Mar 7, 2000
Filed:
Oct 2, 1998
Appl. No.:
9/165549
Inventors:
Lee G. Dante - Merion Station PA
International Classification:
A61K 3144, A61K 31495, A61K 31445, A61K 31135, A61K 3314
US Classification:
514282
Abstract:
Disclosed herein is a method for treating depression associated with alcoholism in a patient comprising administering to the patient a pharmacologically effective dose of an opioid antagonist, and a pharmacologically effective dose of at least one drug compound selected from the group consisting of a tricyclic antidepressant, an a-typical antidepressant, and lithium.
Composition And Method Of Treating Depression Using Naloxone Or Naltrexone In Combination With A Serotonin Reuptake Inhibitor
Composition And Method Of Treating Depression Using Naloxone Or Naltrexone In Combination With A Serotonin Reuptake Inhibitor
US Patent:
5817665, Oct 6, 1998
Filed:
Nov 20, 1995
Appl. No.:
8/560820
Inventors:
Lee G. Dante - Merion Station PA
International Classification:
A61K 3144, A61K 31495, A61K 31445, A61K 31135
US Classification:
514282
Abstract:
This invention relates to a composition and method for treating depression by administering to a patient a pharmacologically effective dose of an opioid antagonist having a pentacyclic nucleus structurally analogous to naltrexone, and a pharmacologically effective dose of a nontricyclic antidepressant.
Composition And Method Of Treating Depression Using A Pentacyclic Nucleus Opioid Antagonist In Combination With A Tricyclic Antidepressant
Composition And Method Of Treating Depression Using A Pentacyclic Nucleus Opioid Antagonist In Combination With A Tricyclic Antidepressant
US Patent:
5856332, Jan 5, 1999
Filed:
Aug 28, 1996
Appl. No.:
8/755795
Inventors:
Lee G. Dante - Merion Station PA
International Classification:
A61K 3144, A61K 3155, A61K 31335, A61K 31135
US Classification:
514282
Abstract:
A new composition and method for treating depression is claimed comprising administering to a patient exhibiting said illness or illnesses a pharmacologically effective dose of an opioid antagonist having a pentacyclic nucleus, and a pharmacologically effective dose of a tricyclic antidepressant.